🧬 The Breakthrough Edition #001

In 2019, Victoria became the first person in the world with sickle cell disease to receive CRISPR gene-editing therapy as part of a clinical trial. At the time, no one knew whether the treatment would work, how long the results would last, or what the future might hold. She wasn't simply receiving a new treatment—she was helping scientists answer one of the biggest questions in modern medicine.